TY  - JOUR
AU  - Ear, Po Hie
AU  - Marinoni, Ilaria
AU  - Dayton, Talya
AU  - Guenter, Rachael
AU  - Dawn, E Quelle
AU  - Battistella, Anna
AU  - Buishand, Floryne O
AU  - Chittaranjan, Suganthi
AU  - Du, Yi-Cheih Nancy
AU  - Marqués, Inés
AU  - Pellegata, Natalia S
AU  - Sadowski, Samira M
AU  - Tirosh, Amit
AU  - April-Monn, Simon
AU  - Aurilia, Cinzia
AU  - Jaskula-Sztul, Renata
AU  - Baena Moreno, Maria Jesús
AU  - Donati, Simone
AU  - English, Katherine A
AU  - Hernández Llorens, María Almudena
AU  - Hodgetts, Harry
AU  - Marini, Francesca
AU  - Martins, Maria
AU  - Palmini, Gaia
AU  - Soldevilla Navarro, Beatriz
AU  - Schrader, Jörg
AU  - Thakker, Rajesh V
AU  - Lines, Kate E
PY  - 2024
DO  - 10.1530/eo-24-0055
SN  - 2634-4793
UR  - https://hdl.handle.net/20.500.14352/118378
T2  - Endocrine Oncology
AB  - Current models for the study of neuroendocrine tumours (NETs) are severely limited. While in vitro (e.g. cell lines), ex vivo (e.g. organoids) and in vivo (e.g. mice) models all exist, each has limitations. To address these limitations and...
LA  - eng
M2  - e240055
PB  - Bioscientifica Ltd.
KW  - Consortium
KW  - Ex vivo
KW  - In vitro
KW  - In vivo
TI  - NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations
TY  - journal article
VL  - 4
ER  -